Product Information For ONC Health IT Certification

MacPractice 20/20 MU versions 5.0 and 5.1

This Complete EHR is ONC 2014 Edition compliant and has been certified by ICSA Labs, an ONC-ACB, in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

MacPractice 20/20 MU versions 5.0 and 5.1 are certified as a complete EHR for the 2014 Edition of the Medicare EHR Incentive Program. The following describes our certification status and disclosure of additional costs and product limitations:

  • Developer: MacPractice, Inc.
  • Certification Dates: 5.0 - June 5, 2014, 5.1 - September 20, 2015
  • Product version: MacPractice 20/20 MU versions 5.0 and 5.1
  • CHPL Product Number: CHP-023187 and CHP-028109

The following is a list of certification criteria to which MacPractice has been tested and certified:

  • 170.314(a)(1) COMPUTERIZED PROVIDER ORDER ENTRY
  • 170.314(a)(2) DRUG-DRUG, DRUG-ALLERGY INTERACTION CHECKS
  • 170.314(a)(3) DEMOGRAPHICS
  • 170.314(a)(4) VITAL SIGNS, BODY MASS INDEX, AND GROWTH CHARTS
  • 170.314(a)(5) PROBLEM LIST
  • 170.314(a)(6) MEDICATION LIST
  • 170.314(a)(7) MEDICATION ALLERGY LIST
  • 170.314(a)(8) CLINICAL DECISION SUPPORT
  • 170.314(a)(9) ELECTRONIC NOTES
  • 170.314(a)(10) DRUG-FORMULARY CHECKS
  • 170.314(a)(11) SMOKING STATUS
  • 170.314(a)(12) IMAGE RESULTS
  • 170.314(a)(13) FAMILY HEALTH HISTORY
  • 170.314(a)(14) PATIENT LIST CREATION
  • 170.314(a)(15) PATIENT-SPECIFIC EDUCATION RESOURCES
  • 170.314(b)(1) TRANSITIONS OF CARE - RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES
  • 170.314(b)(2) TRANSITIONS OF CARE - CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES
  • 170.314(b)(3) ELECTRONIC PRESCRIBING
  • 170.314(b)(4) CLINICAL INFORMATION RECONCILIATION
  • 170.314(b)(5) INCORPORATE LABORATORY TESTS AND VALUES/RESULTS
  • 170.314(b)(7) DATA PORTABILITY
  • 170.314(c)(1) CLINICAL QUALITY MEASURES - CAPTURE AND EXPORT
  • 170.314(c)(2) CLINICAL QUALITY MEASURES - IMPORT AND CALCULATE
  • 170.314(c)(3) CLINICAL QUALITY MEASURES - ELECTRONIC SUBMISSION
  • 170.314(d)(1) AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION
  • 170.314(d)(2) AUDITABLE EVENTS AND TAMPER-RESISTANCE
  • 170.314(d)(3) AUDIT REPORT(S)
  • 170.314(d)(4) AMENDMENTS
  • 170.314(d)(5) AUTOMATIC LOG-OFF
  • 170.314(d)(6) EMERGENCY ACCESS
  • 170.314(d)(7) END-USER DEVICE ENCRYPTION
  • 170.314(d)(8) INTEGRITY
  • 170.314(d)(9) ACCOUNTING OF DISCLOSURES (OPTIONAL)
  • 170.314(e)(1) VIEW, DOWNLOAD, AND TRANSMIT TO 3RD PARTY
  • 170.314(e)(2) CLINICAL SUMMARY
  • 170.314(e)(3) SECURE MESSAGING
  • 170.314(f)(1) IMMUNIZATION INFORMATION
  • 170.314(f)(2) TRANSMISSION TO IMMUNIZATION REGISTRIES
  • 170.314(f)(3) TRANSMISSION TO PUBLIC HEALTH AGENCIES - SYNDROMIC SURVEILLANCE
  • 170.314(g)(2) AUTOMATED MEASURE CALCULATION
  • 170.314(g)(3) SAFETY-ENHANCED DESIGN
  • 170.314(g)(4) QUALITY MANAGEMENT SYSTEM

The following is a list of clinical quality measures to which MacPractice has been tested and certified:

  • CMS2 PREVENTIVE CARE AND SCREENING: SCREENING FOR CLINICAL DEPRESSION AND FOLLOW-UP PLAN
  • CMS22 PREVENTIVE CARE AND SCREENING: SCREENING FOR HIGH BLOOD PRESSURE AND FOLLOW-UP DOCUMENTED
  • CMS50 CLOSING THE REFERRAL LOOP: RECEIPT OF SPECIALIST REPORT
  • CMS52 HIV/AIDS: PNEUMOCYSTIS JIROVECI PNEUMONIA (PCP) PROPHYLAXIS
  • CMS56 FUNCTIONAL STATUS ASSESSMENT FOR HIP REPLACEMENT
  • CMS61 PREVENTIVE CARE AND SCREENING: CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C) TEST PERFORMED
  • CMS62 HIV/AIDS: MEDICAL VISIT
  • CMS64 PREVENTIVE CARE AND SCREENING: RISK- STRATIFIED CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C)
  • CMS65 HYPERTENSION: IMPROVEMENT IN BLOOD PRESSURE
  • CMS66 FUNCTIONAL STATUS ASSESSMENT FOR KNEE REPLACEMENT
  • CMS68 DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL RECORD
  • CMS69 PREVENTIVE CARE AND SCREENING: BODY MASS INDEX (BMI) SCREENING AND FOLLOW-UP
  • CMS74 PRIMARY CARIES PREVENTION INTERVENTION AS OFFERED BY PRIMARY CARE PROVIDERS, INCLUDING DENTISTS
  • CMS75 CHILDREN WHO HAVE DENTAL DECAY OR CAVITIES
  • CMS77 HIV/AIDS: RNA CONTROL FOR PATIENTS WITH HIV
  • CMS82 MATERNAL DEPRESSION SCREENING
  • CMS117 CHILDHOOD IMMUNIZATION STATUS
  • CMS122 DIABETES: HEMOGLOBIN A1C POOR CONTROL
  • CMS123 DIABETES: FOOT EXAM
  • CMS124 CERVICAL CANCER SCREENING
  • CMS125 BREAST CANCER SCREENING
  • CMS126 USE OF APPROPRIATE MEDICATIONS FOR ASTHMA
  • CMS127 PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS
  • CMS128 ANTI-DEPRESSANT MEDICATION MANAGEMENT
  • CMS129 PROSTATE CANCER: AVOIDANCE OF OVERUSE OF BONE SCAN FOR STAGING LOW RISK PROSTATE CANCER PATIENTS
  • CMS130 COLORECTAL CANCER SCREENING
  • CMS131 DIABETES: EYE EXAM
  • CMS132 CATARACTS: COMPLICATIONS WITHIN 30 DAYS FOLLOWING CATARACT SURGERY REQUIRING ADDITIONAL SURGICAL PROCEDURES
  • CMS133 CATARACTS: 20/40 OR BETTER VISUAL ACUITY WITHIN 90 DAYS FOLLOWING CATARACT SURGERY
  • CMS134 DIABETES: URINE PROTEIN SCREENING
  • CMS135 HEART FAILURE (HF): ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITOR OR ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
  • CMS137 INITIATION AND ENGAGEMENT OF ALCOHOL AND OTHER DRUG DEPENDENCE TREATMENT
  • CMS138 PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION
  • CMS139 SCREENING FOR FUTURE FALL RISK
  • CMS140 BREAST CANCER: HORMONAL THERAPY FOR STAGE IC-IIIC ESTROGEN RECEPTOR/PROGESTERONE RECEPTOR (ER/PR) POSITIVE BREAST CANCER
  • CMS141 COLON CANCER: CHEMOTHERAPY FOR AJCC STAGE III COLON CANCER PATIENTS
  • CMS142 DIABETIC RETINOPATHY: COMMUNICATION WITH THE PHYSICIAN MANAGING ONGOING DIABETES CARE
  • CMS143 PRIMARY OPEN ANGLE GLAUCOMA (POAG): OPTIC NERVE EVALUATION
  • CMS144 HEART FAILURE (HF): BETA-BLOCKER THERAPY FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
  • CMS145 CORONARY ARTERY DISEASE (CAD): BETA-BLOCKER THERAPY- PRIOR MYOCARDIAL INFARCTION (MI) OR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVEF <40%)
  • CMS148 HEMOGLOBIN A1C TEST FOR PEDIATRIC PATIENTS
  • CMS149 DEMENTIA: COGNITIVE ASSESSMENT
  • CMS153 CHLAMYDIA SCREENING FOR WOMEN
  • CMS154 APPROPRIATE TREATMENT FOR CHILDREN WITH UPPER RESPIRATORY INFECTION (URI)
  • CMS155 WEIGHT ASSESSMENT AND COUNSELING FOR NUTRITION AND PHYSICAL ACTIVITY FOR CHILDREN AND ADOLESCENTS
  • CMS156 USE OF HIGH-RISK MEDICATIONS IN THE ELDERLY
  • CMS157 ONCOLOGY: MEDICAL AND RADIATION – PAIN INTENSITY QUANTIFIED
  • CMS158 PREGNANT WOMEN THAT HAD HBSAG TESTING
  • CMS159 DEPRESSION REMISSION AT TWELVE MONTHS
  • CMS161 MAJOR DEPRESSIVE DISORDER (20/20D): SUICIDE RISK ASSESSMENT
  • CMS163 DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT
  • CMS164 ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC
  • CMS167 DIABETIC RETINOPATHY: DOCUMENTATION OF PRESENCE OR ABSENCE OF MACULAR EDEMA AND LEVEL OF SEVERITY OF RETINOPATHY
  • CMS177 CHILD AND ADOLESCENT MAJOR DEPRESSIVE DISORDER: SUICIDE RISK ASSESSMENT
  • CMS182 ISCHEMIC VASCULAR DISEASE (IVD): COMPLETE LIPID PANEL AND LDL CONTROL

Mandatory Disclosure Statement

This certified product-version requires additional costs, contractual obligations, and technical and practical limitations as described below:

Additional Costs

MacPractice, Inc offers both a standard MacPractice 20/20 5.0 or 5.1 version that does not offer the capabilities needed to meet the objectives of the EHR Incentive Program, and a MacPractice 20/20 MU version 5.0 or 5.1 option that provides the capabilities needed to meet the objectives of the EHR Incentive program. MacPractice 20/20 MU version 5.0 or 5.1 is the EHR technology that has been tested and certified as a Complete EHR. MacPractice, Inc. charges an initial fee for MacPractice 20/20 MU version 5.0 or 5.1. In addition to the fee, MacPractice charges a recurring yearly support fee per provider. MacPractice licensees are required to sign an agreement when purchasing MacPractice 20/20 MU version 5.0 or 5.1, which lists these fees.

The initial and recurring fees cover all features and capabilities which are not included in the standard MacPractice for the specific purpose of meeting the objectives of the EHR Incentive Program including, but not limited to; CPOE, drug-drug and drug-allergy interaction checks, generation and transmission of permissible prescriptions electronically, drug formulary checks, medication reconciliation, incorporation of clinical lab test results, submission of electronic data to immunization registries, submission of syndromic surveillance data to public health agencies, and doctor to doctor direct secure electronic transmission of summary of care records upon transition of patients to another provider of care.

The additional types of costs that an Eligible Provider would pay to implement this Complete EHR's capabilities in order to attempt to meet meaningful use objectives and measures or to achieve any other use within the scope of the health IT's certification include: monthly service fees for using ePrescribe, monthly lab interface support fees in some instances, integration fees for health information exchange, and an annual fee for MacPractice continued development and product support via toll free telephone, live chat, email, and remote access.

Limitations

EHR Incentive Program objectives cannot be met with the standard MacPractice 20/20 5.0 or 5.1 version software. Meaningful Use can only be achieved with the purchase of MacPractice 20/20 MU version 5.0 or 5.1. MacPractice licensees are required to maintain annual service agreements and upon expiration, many functionalities required for achieving Meaningful Use are disabled. The certified MacPractice product requires an internet connection to perform many required tasks and for licensing verification.

Third Parties

The certified MacPractice 20/20 MU version 5.0 or 5.1 product is dependent upon third parties for some capabilities. These third parties are NewCrop for electronic prescribing, drug interaction and formulary checks and other functions. Updox is utilized to facilitate Direct Messaging. MedLinePlus is used to provide Infobutton service. MacPractice licensees may not choose alternatives to these third parties and are not required to enter into separate agreements with the third parties.

Product Information

The preceding mandatory disclosure language will be displayed on the MacPractice website at the following location: https://www.macpractice.com/20/20/meaningful-use-product-information/


MacPractice Billing Services

Your clinical skills combined with our medical billing expertise will keep your practice financially sound while you focus on patient care. You’ll collect faster, even amid declining revenues and increasing billing complexity.

Learn more

Upcoming Live Webinars

Is MacPractice Right for Me and My Practice?

This webinar will help you decide whether or not MacPractice is right for your practice. We will discuss the state...

This webinar will help you decide whether or not MacPractice is right for your practice. We will discuss the state of Apple products in healthcare, along with what our current clients love most about MacPractice. The live Q&A session at the end is a great way to learn answers to questions you didn’t even know you had!  This webinar is for prospective clients of MacPractice. Current MacPractice clients can find training in the Help section of the software.

Meaningful Use

MacPractice 5.0 and MacPractice 5.1 Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs.

Learn more